Search clinical trials for: Zalifrelimab

Total 5 results

UroGen Pharma Ltd.

Recruiting

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of Bladder

United States, Italy, Spain
Ann & Robert H Lurie Children's Hospital of Chicago
Dana-Farber Cancer Institute; University of Calgary; Children's Hospital of Orange...

Recruiting

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant

United States
Agenus Inc.
Betta Pharmaceuticals Co., Ltd.

Withdrawn

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

Cervical Cancer

China
Agenus Inc.

Available

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Cancer
Nelum Corp
Apices Soluciones S.L.; Agenus Inc.

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NUMANTIA)

Pancreatic Ductal Adenocarcinoma

Spain

3

Subscribe